Risks for breast cancer when there is a family history of the disease are usually calculated using data from segregation analyses which favour a single dominant gene with high penetrance. There are, however, at least three loci known to be associated with familial breast cancer (p53, BRCA1, and an as yet unpublished locus) and the frequencies and penetrances of these genes are not likely to be the same. We have attempted to address the problem of which genetic parameters should be used to calculate risks for different patterns offamilial breast cancer.
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Data from 384 nuclear families ascertained through a proband selected for early onset breast cancer were subjected to complex segregation analysis, correcting for ascertainment bias resulting from selection for severe phenotype. Age of onset of breast cancer, incorporated as severity, provides additional information to the segregation model over and above that given by assigning liability classes on the basis of age at observation. The use of this additional parameter in the analysis is described. There is fair agreement between estimates from this sample and previous predictions from consecutive probands and consultands. The differences suggest more than one rare dominant gene for susceptibility to breast cancer, with different penetrances. Although refinements of segregation analysis will help to delineate these different genes, perfect resolution will require identification ofthe mutant alleles. Methods to estimate genetic parameters under genotype specific mortality need to be developed. Meanwhile, we suggest that high and low estimates of penetrance be used in risk estimation for genetic counselling, and as a guide to candidates for entry into clinical trials of screening and chemoprevention in breast cancer.
(JMed Genet 1994;31: [944] [945] [946] [947] [948] [949] Breast cancer affects about 1 in 12 women in the UK and 1 in 9 women in the USA, but the majority of women are affected in the peri-or postmenopausal years. It is on the basis of a higher incidence in these years that the UK National Breast Screening Programme invites women between 50 and 64 years of age for screening mammograms. A small proportion ofwomen are affected at younger ages. Previous segregation studies have clearly shown that rare dominant genes with high penetrance are responsible for a proportion of breast cancer cases'-4 and that the risks to unaffected close relatives increase with decreasing age of the affected relative(s).> Although the role of rare dominant genes in familial breast cancer is well established, most of the relevant genes have not been isolated and it is not yet possible to look for mutations in all the relevant genes for any individual person. Therefore segregation analysis is still required for risk assessment. Segregation analysis is a statistical method which seeks to define the mode of inheritance of a disease in a population and to define genetic parameters for diseases inherited in a mendelian fashion. A number of genetic hypotheses are considered during the analysis of a set of data and the most likely hypothesis or model is fitted. Where pedigrees are ascertained through clearly defined selection criteria, ascertainment bias can be fully corrected for5 and the results can be applied to the population from which the sample was taken. Such analyses for breast cancer have consistently found evidence of a dominantly inherited genetic predisposition, where the putative gene has a low frequency and a high penetrance in the population. The choice of model34 for risk calculations makes some difference to the actual risk figure arrived at but the differences are usually small. The effect of genotype specific mortality on gene frequencies at particular ages is poorly known. One would expect the population gene frequency to fall with increasing age owing to disease specific mortality. All probands were affected with breast cancer.
Patients were approached at their routine follow up clinic appointment and only one patient declined interview. For the remaining 127 probands, family history including age and cause of death were documented in first and second degree relatives and wherever possible reported diagnoses of breast cancer were confirmed from medical records or death certificates. A total of 176/200 (88%) of reported breast cancers were confirmed from records or death certificates. The remainder were reported by a first degree relative to have had a mastectomy or radiotherapy or both. The age at last observation for all family members was recorded, and age at onset of breast cancer, where known, was also documented. Nuclear families in this dataset were coded for single selection, which in the COMDS computer program is conditional on severity.7 In two pedigrees an affected third degree relative was identified and coded for truncate selection as a secondary proband within their nuclear family with the proband as the pointer. This dataset will be called the Wessex sample.
Iselius et a!2 reported on two British series (one selected through consecutive probands with breast cancer and the other through normal consultands). This dataset will be called the London sample and was coded as described SV1   SV5  SV5  SV5  SV5  SV5  SV5  SV5  SV5  25-29   SV1   SV4  SV4  SV4  SV4  SV4  SV4  SV4  30-34  SV1  SV3  SV3  SV3  SV3  SV3  SV3  35-39   SV1   SV2  SV2  SV2  SV2  SV2  40+   SV1   SV1   SV1 SV1 SV1 Severity frequencies (SVI.l..., SV5): 0 9617, 0 0241, 0 0106, 0 00311, 0-0005. previously, except that isolated cases were assigned to single selection.
LIABILITY CLASS
The Wessex and London datasets were analysed in parallel and as a pooled set. The data were handled in the same way after the initial coding differences, which take account of the well defined ascertainment biases. Each person whether affected or not was placed in a liability class based on sex and age at last observation (table 1) . Males were assigned to the lowest liability class (LI = 1).
SEVERITY
The POINTER program8 uses age at last observation to assign subjects to liability classes for segregation analysis. In a disease such as breast cancer, the earlier the age at onset, the more likely a person is to carry the high risk genotype. The 10 year survival after a diagnosis of breast cancer is about 50% in the UK for all stages, so a substantial number of those women diagnosed in one liability class would be observed in a later liability class and the information about a much earlier age at onset would be lost. In order to retrieve the information about age at onset we have used the COMDS program for analysis incorporating age at onset as severity through a parameter "S". Where the interval between age at onset and age at observation is large, and age at onset is young, the person is assigned the more severe class; conversely where age at onset is within the same range as age at observation, the liability class assigned takes account of the age at onset to a large extent and the least severe class is assigned. In the final analysis the magnitude of the parameter S gives an indication of the extent to which the information contained in S contributes towards distinguishing alternative genetic models. Where S tends towards 1-0, a large proportion of information has been retrieved using severity classes, where S tends towards 0 then very little additional information comes from assigning severity class to individual persons.
To include this parameter, we used the scheme set out in table 2. A severity class from SV1 to SV5 was assigned to all affected cases. Where the age at onset was 40 years or greater, cases were assigned to the least severe class 1 fig 1) , with penetrance reaching 100% by 69 years of age in the early onset (Wessex) dataset compared to 77% at the same age in the London dataset. consultand by a given age (j) with a particular family history is given by the likelihood of the pedigree (F) with the consultand affected at that age divided by the likelihood of the pedigree with the consultand omitted.
The main likelihoods are calculated from the segregation parameters in each of the models using the computer program MENDEL"1 and essentially provide for each pedigree member a probability that they carry a high risk genotype based on age and phenotype (affected or unaffected).
[op the disease Discussion intervals using The incidence of breast cancer increases with oresented in fig increasing age and is relatively rare below the mness for the age of40 years. Data from genetic epidemiology studies ofbreast cancer are likely to be deficient in numbers of early onset cases. The models a 0 thus reflect an average of the parameters from all the dominant genes for breast cancer in the population. We selected cases of breast cancer specifically for early onset to try to refine a segregation model reflecting a gene or genes predisposing to unusually early onset breast cancer. We have addressed the problems of correcting for ascertainment bias in this sample and incorporating information about age of onset as an additional parameter "S" for severity which has not been included in previous analyses using POINTER. .7
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. Severity. This is an additional parameter which can be estimated (using COMDS) to retrieve information about age at onset from the data, some of which is lost when age at observation (liability class) alone is used. Single selectioni. Used to define families ascertained through a single affected proband taken at random from a defined population, giving an ascertainment probability proportional to the number of affected in the family. Truncate selectioni. Used to define families ascertained through at least one affected child, where the ascertainment probability for the family does not depend on the number of affected children if greater than 1. Pointer. This is the person outside a nuclear family through whom that nuclear pedigree has been ascertained. Her relationship to the closest relative in each nuclear pedigree is reflected in the coding.
